Medical Care

Global Biosimilar Monoclonal Antibody Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Biosimilar Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar Monoclonal Antibody.
The Biosimilar Monoclonal Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilar Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilar Monoclonal Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis
Segment by Type
Limited Dilution Method
Micromanipulation
Soft Agar Plate Method
Others
Segment by Application
Chronic & Autoimmune Diseases
Oncology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar Monoclonal Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Limited Dilution Method
1.2.3 Micromanipulation
1.2.4 Soft Agar Plate Method
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biosimilar Monoclonal Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Chronic & Autoimmune Diseases
1.3.3 Oncology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilar Monoclonal Antibody Market Perspective (2020-2031)
2.2 Global Biosimilar Monoclonal Antibody Growth Trends by Region
2.2.1 Global Biosimilar Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biosimilar Monoclonal Antibody Historic Market Size by Region (2020-2025)
2.2.3 Biosimilar Monoclonal Antibody Forecasted Market Size by Region (2026-2031)
2.3 Biosimilar Monoclonal Antibody Market Dynamics
2.3.1 Biosimilar Monoclonal Antibody Industry Trends
2.3.2 Biosimilar Monoclonal Antibody Market Drivers
2.3.3 Biosimilar Monoclonal Antibody Market Challenges
2.3.4 Biosimilar Monoclonal Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue
3.1.1 Global Top Biosimilar Monoclonal Antibody Players by Revenue (2020-2025)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Biosimilar Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimilar Monoclonal Antibody Revenue
3.4 Global Biosimilar Monoclonal Antibody Market Concentration Ratio
3.4.1 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibody Revenue in 2024
3.5 Global Key Players of Biosimilar Monoclonal Antibody Head office and Area Served
3.6 Global Key Players of Biosimilar Monoclonal Antibody, Product and Application
3.7 Global Key Players of Biosimilar Monoclonal Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilar Monoclonal Antibody Breakdown Data by Type
4.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Type (2020-2025)
4.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2026-2031)
5 Biosimilar Monoclonal Antibody Breakdown Data by Application
5.1 Global Biosimilar Monoclonal Antibody Historic Market Size by Application (2020-2025)
5.2 Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biosimilar Monoclonal Antibody Market Size (2020-2031)
6.2 North America Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biosimilar Monoclonal Antibody Market Size by Country (2020-2025)
6.4 North America Biosimilar Monoclonal Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilar Monoclonal Antibody Market Size (2020-2031)
7.2 Europe Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biosimilar Monoclonal Antibody Market Size by Country (2020-2025)
7.4 Europe Biosimilar Monoclonal Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilar Monoclonal Antibody Market Size (2020-2031)
8.2 Asia-Pacific Biosimilar Monoclonal Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilar Monoclonal Antibody Market Size (2020-2031)
9.2 Latin America Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2020-2025)
9.4 Latin America Biosimilar Monoclonal Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilar Monoclonal Antibody Market Size (2020-2031)
10.2 Middle East & Africa Biosimilar Monoclonal Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocon
11.1.1 Biocon Company Details
11.1.2 Biocon Business Overview
11.1.3 Biocon Biosimilar Monoclonal Antibody Introduction
11.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.1.5 Biocon Recent Development
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Details
11.2.2 Accord Healthcare Business Overview
11.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Introduction
11.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.2.5 Accord Healthcare Recent Development
11.3 AET Biotech
11.3.1 AET Biotech Company Details
11.3.2 AET Biotech Business Overview
11.3.3 AET Biotech Biosimilar Monoclonal Antibody Introduction
11.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.3.5 AET Biotech Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Biosimilar Monoclonal Antibody Introduction
11.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.4.5 Amgen Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Biosimilar Monoclonal Antibody Introduction
11.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.5.5 Celltrion Recent Development
11.6 Reddy's Laboratories
11.6.1 Reddy's Laboratories Company Details
11.6.2 Reddy's Laboratories Business Overview
11.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Introduction
11.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.6.5 Reddy's Laboratories Recent Development
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Hospira Business Overview
11.7.3 Hospira Biosimilar Monoclonal Antibody Introduction
11.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.7.5 Hospira Recent Development
11.8 3SBio
11.8.1 3SBio Company Details
11.8.2 3SBio Business Overview
11.8.3 3SBio Biosimilar Monoclonal Antibody Introduction
11.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.8.5 3SBio Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Biosimilar Monoclonal Antibody Introduction
11.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.9.5 Allergan Recent Development
11.10 Alvartis
11.10.1 Alvartis Company Details
11.10.2 Alvartis Business Overview
11.10.3 Alvartis Biosimilar Monoclonal Antibody Introduction
11.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2020-2025)
11.10.5 Alvartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Limited Dilution Method
Table 3. Key Players of Micromanipulation
Table 4. Key Players of Soft Agar Plate Method
Table 5. Key Players of Others
Table 6. Global Biosimilar Monoclonal Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biosimilar Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biosimilar Monoclonal Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biosimilar Monoclonal Antibody Market Share by Region (2020-2025)
Table 10. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biosimilar Monoclonal Antibody Market Share by Region (2026-2031)
Table 12. Biosimilar Monoclonal Antibody Market Trends
Table 13. Biosimilar Monoclonal Antibody Market Drivers
Table 14. Biosimilar Monoclonal Antibody Market Challenges
Table 15. Biosimilar Monoclonal Antibody Market Restraints
Table 16. Global Biosimilar Monoclonal Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biosimilar Monoclonal Antibody Market Share by Players (2020-2025)
Table 18. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibody as of 2024)
Table 19. Ranking of Global Top Biosimilar Monoclonal Antibody Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biosimilar Monoclonal Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biosimilar Monoclonal Antibody, Headquarters and Area Served
Table 22. Global Key Players of Biosimilar Monoclonal Antibody, Product and Application
Table 23. Global Key Players of Biosimilar Monoclonal Antibody, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilar Monoclonal Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2020-2025)
Table 27. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biosimilar Monoclonal Antibody Revenue Market Share by Type (2026-2031)
Table 29. Global Biosimilar Monoclonal Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2020-2025)
Table 31. Global Biosimilar Monoclonal Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2026-2031)
Table 33. North America Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biosimilar Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biosimilar Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biosimilar Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biosimilar Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biosimilar Monoclonal Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biosimilar Monoclonal Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biosimilar Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biosimilar Monoclonal Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 48. Biocon Company Details
Table 49. Biocon Business Overview
Table 50. Biocon Biosimilar Monoclonal Antibody Product
Table 51. Biocon Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 52. Biocon Recent Development
Table 53. Accord Healthcare Company Details
Table 54. Accord Healthcare Business Overview
Table 55. Accord Healthcare Biosimilar Monoclonal Antibody Product
Table 56. Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 57. Accord Healthcare Recent Development
Table 58. AET Biotech Company Details
Table 59. AET Biotech Business Overview
Table 60. AET Biotech Biosimilar Monoclonal Antibody Product
Table 61. AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 62. AET Biotech Recent Development
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Biosimilar Monoclonal Antibody Product
Table 66. Amgen Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Celltrion Company Details
Table 69. Celltrion Business Overview
Table 70. Celltrion Biosimilar Monoclonal Antibody Product
Table 71. Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 72. Celltrion Recent Development
Table 73. Reddy's Laboratories Company Details
Table 74. Reddy's Laboratories Business Overview
Table 75. Reddy's Laboratories Biosimilar Monoclonal Antibody Product
Table 76. Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 77. Reddy's Laboratories Recent Development
Table 78. Hospira Company Details
Table 79. Hospira Business Overview
Table 80. Hospira Biosimilar Monoclonal Antibody Product
Table 81. Hospira Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 82. Hospira Recent Development
Table 83. 3SBio Company Details
Table 84. 3SBio Business Overview
Table 85. 3SBio Biosimilar Monoclonal Antibody Product
Table 86. 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 87. 3SBio Recent Development
Table 88. Allergan Company Details
Table 89. Allergan Business Overview
Table 90. Allergan Biosimilar Monoclonal Antibody Product
Table 91. Allergan Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 92. Allergan Recent Development
Table 93. Alvartis Company Details
Table 94. Alvartis Business Overview
Table 95. Alvartis Biosimilar Monoclonal Antibody Product
Table 96. Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2020-2025) & (US$ Million)
Table 97. Alvartis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report


List of Figures
Figure 1. Biosimilar Monoclonal Antibody Picture
Figure 2. Global Biosimilar Monoclonal Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilar Monoclonal Antibody Market Share by Type: 2024 VS 2031
Figure 4. Limited Dilution Method Features
Figure 5. Micromanipulation Features
Figure 6. Soft Agar Plate Method Features
Figure 7. Others Features
Figure 8. Global Biosimilar Monoclonal Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biosimilar Monoclonal Antibody Market Share by Application: 2024 VS 2031
Figure 10. Chronic & Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Others Case Studies
Figure 13. Biosimilar Monoclonal Antibody Report Years Considered
Figure 14. Global Biosimilar Monoclonal Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Biosimilar Monoclonal Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biosimilar Monoclonal Antibody Market Share by Region: 2024 VS 2031
Figure 17. Global Biosimilar Monoclonal Antibody Market Share by Players in 2024
Figure 18. Global Top Biosimilar Monoclonal Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibody as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibody Revenue in 2024
Figure 20. North America Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Biosimilar Monoclonal Antibody Market Share by Country (2020-2031)
Figure 22. United States Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biosimilar Monoclonal Antibody Market Share by Country (2020-2031)
Figure 26. Germany Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biosimilar Monoclonal Antibody Market Share by Region (2020-2031)
Figure 34. China Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biosimilar Monoclonal Antibody Market Share by Country (2020-2031)
Figure 42. Mexico Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biosimilar Monoclonal Antibody Market Share by Country (2020-2031)
Figure 46. Turkey Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Biosimilar Monoclonal Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 50. Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 51. AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 53. Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 54. Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 55. Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 56. 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 57. Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 58. Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies